February 2016 Archive
Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics
Monday, February 29, 2016
![](https://www.umventures.org/sites/default/files/styles/medium/public/MPower%20Logo_UMVentures_FINAL-01_0.png?itok=UCfRgHEQ)
DEADLINE 3/11: UM Ventures Seed Grant Program
Wednesday, February 24, 2016
![Tedco Logo Tedco Logo](https://www.umventures.org/sites/default/files/styles/medium/public/20130530_TedcoLogo.jpg?itok=rVKFFsKp)
DEADLINE 4/15: Applications For TEDCO’S Life Science Investment Fund Now Being Accepted
Wednesday, February 24, 2016
![Remedy Pharmaceuticals Remedy Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/RemedyNew.jpg?itok=-eidzljv)
Remedy Pharmaceuticals Announces Additional Results From Phase 2 CNS-Related Edema Study of CIRARA™
Tuesday, February 23, 2016